Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|September 9, 2022
Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic FibrosisCarsten Schwarz, Claudio Procaccianti, Laura Costa, et al.
BMJ Open Respiratory Research|May 3, 2024
Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapyPierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, et al.
Mycopathologia|July 18, 2024
Detection of Specific IgE against Molds Involved in Allergic Bronchopulmonary Mycoses in Patients with Cystic FibrosisCoralie Barrera, Carsten Schwarz, Laurence Delhaes, et al.
Frontiers in Pharmacology|August 19, 2021
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic FibrosisPatrick O Hanafin, Isabelle Sermet-Gaudelus, Matthias Griese, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 27, 2020
Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse eventsCarsten Schwarz, Sivagurunathan Sutharsan, Ralph Epaud, et al.
Frontiers in Pharmacology|May 19, 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-ScoreJochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Frontiers in Pharmacology|June 20, 2022
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-ScoreJochen G Mainz, Carlos Zagoya, Louise Polte, et al.
The Lancet Regional Health. Europe|August 9, 2023
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF RegistrySivagurunathan Sutharsan, Stefanie Dillenhoefer, Matthias Welsner, et al.
Investigative Radiology|July 9, 2015
Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parametersDiane M Renz, Oriane Scholz, Joachim Böttcher, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 23, 2025
Validation of the CFAbd-Score.kid©, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosisPauline Sadrieh, Lilith Bechinger, Franziska Duckstein, et al.
Pageof 9